Abstract
The long-acting thyroid stimulator (LATS) has been said to be the pathogenetic factor of the thyroid autonomy or hyperfunction in Graves' disease. Two patients had the ophthalmopathy and pretibial myxedema of Graves' disease occurring with Hashimoto's thyroiditis. Both patients had suppressed thyroid function in response to exogenous thyroid hormone in spite of the presence of high levels of LATS in their serums. The long-acting thyroid stimulator may not be the cause of the fixed thyroid function of Graves' disease.
Talk to us
Join us for a 30 min session where you can share your feedback and ask us any queries you have
Schedule a callDisclaimer: All third-party content on this website/platform is and will remain the property of their respective owners and is provided on "as is" basis without any warranties, express or implied. Use of third-party content does not indicate any affiliation, sponsorship with or endorsement by them. Any references to third-party content is to identify the corresponding services and shall be considered fair use under The CopyrightLaw.
